STILBESTROL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Stilbestrol, and when can generic versions of Stilbestrol launch?
Stilbestrol is a drug marketed by Bristol Myers Squibb and Tablicaps and is included in seven NDAs.
The generic ingredient in STILBESTROL is diethylstilbestrol. There are twenty-six drug master file entries for this compound. Additional details are available on the diethylstilbestrol profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for STILBESTROL?
- What are the global sales for STILBESTROL?
- What is Average Wholesale Price for STILBESTROL?
Summary for STILBESTROL
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 7 |
Raw Ingredient (Bulk) Api Vendors: | 119 |
Patent Applications: | 4,437 |
DailyMed Link: | STILBESTROL at DailyMed |
US Patents and Regulatory Information for STILBESTROL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bristol Myers Squibb | STILBESTROL | diethylstilbestrol | INJECTABLE;INJECTION | 004056-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Tablicaps | STILBESTROL | diethylstilbestrol | TABLET, DELAYED RELEASE;ORAL | 083003-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Bristol Myers Squibb | STILBESTROL | diethylstilbestrol | INJECTABLE;INJECTION | 004056-006 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Tablicaps | STILBESTROL | diethylstilbestrol | TABLET;ORAL | 083006-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Tablicaps | STILBESTROL | diethylstilbestrol | TABLET, DELAYED RELEASE;ORAL | 083005-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |